IFNG and Q fever: The C. burnetii-specific whole-blood interferon-γ (IFNγ) production assay showed promising results in differentiating QFS patients from Q fever seropositive controls and further implementation of an IFNγ/interleukin-2 (IL-2) ratio helped differentiate QFS patients from chronic Q fever patients [8].